Preloader Close
  • Twisted nanophotonic technology for integrated chiroptical sensing of drugs on a chip
At a glance

TwistedNano

Project Focus

Chirality is the asymmetric property of an object that makes it distinguishable from its mirror image

Project Objectives

TwistedNano targets the EU priority area “Health and Safety” by developing a set of new-generation

Project Organization

The workplan structure is based on a strong collaboration between all partners

TwistedNano will be developed by a consortium of 7 European Academic Institutions (UnivAQ – Università degli Studi dell’Aquila, Italy,  MPL – Max Planck Institute for The Science of Light, Germany, EPFL – Ecole Polytechnique Fédérale de Lausanne, Switzerland, CNRS – Centre national de la recherche scientifique, France, IIT – Istituto Italiano di Tecnologia, Italy, ICFO – The Institute of Photonic Sciences, Spain and The University of Cyprus ), a global industrial player in pharmaceutics (Dompé Farmaceutici S.p.A., Italy) and a young start-up(Foresee Biosystems, Italy).

TwistedNano aims at developing an innovative platform to measure tiny amounts of chiral drugs.

Publications

Recent scientific articles

Polarization-Shaped Strong Field Control Over Valley Polarization with Mid-IR Light

Tyulnev, J. Poborska, A. Jiménez-Galán, L. Vamos, O. Smirnova, M. Ivanov, J. Biegert

Proc. 8th Int. Conf. Attosecond Science and Technology, 195-202 (2024).

Attosecond Physics and Quantum Information Science

M. Lewenstein, N. Baldelli, U. Bhattacharya, J. Biegert, M. F. Ciappina, T. Grass, P. T. Grochowski, A. S. Johnson, Th. Lamprou, A. S. Maxwell, A. Ordóñez, E. Pisanty, J. Rivera-Dean, P. Stammer, P. Tzallas

Proc. 8th Int. Conf. Attosecond Science and Technology, 27-63 (2024).

Project details

01/04/2022

48 months
€3.197.925
Andrea Marini (UNIVAQ)